Femasys Appoints John Canning COO, Grants 150,000-Share Stock Option
Femasys appointed medical device veteran John Canning as COO to advance operational execution and commercial growth of its fertility and permanent birth control offerings. The company granted him an inducement option for 150,000 shares at closing price, vesting 25% annually over four years.
1. Appointment of Chief Operating Officer
Femasys has named John Canning as Chief Operating Officer to enhance operational execution and support commercialization efforts for its fertility and non-surgical permanent birth control portfolio.
2. Executive’s MedTech Track Record
Canning has over 25 years in global medical device operations and technology leadership, most recently serving as COO and CTO at Terumo Aortic and earlier manufacturing roles at Medtronic Vascular.
3. Terms of Stock Option Grant
Effective on his start date, Canning received an inducement option for 150,000 common shares at the stock’s closing price, vesting 25% on each anniversary over four years, approved by Femasys’ Compensation Committee.
4. Strategic Growth Implications
His appointment and oversight aim to accelerate the commercial rollout of FemaSeed® and FemBloc®, strengthen manufacturing and scale operations, and drive global market expansion.